National lipid association recommendations for patient-centered management of dyslipidemia: Part 2

Terry A. Jacobson; Kevin C. Maki; Carl E. Orringer; Peter H. Jones; Penny Kris-Etherton; Geeta Sikand; Ralph La Forge; Stephen R. Daniels; Don P. Wilson; Pamela B. Morris; Robert A. Wild; Scott M. Grundy; Martha Daviglus; Keith C. Ferdinand; Krishnaswami Vijayaraghavan; Prakash C. Deedwania; Judith A. Aberg; Katherine P. Liao; James M. McKenney; Joyce L. Ross; Lynne T. Braun; Matthew K. Ito; Harold E. Bays; W. Virgil Brown

doi:10.1016/j.jacl.2015.09.002

National lipid association recommendations for patient-centered management of dyslipidemia: Part 2

Terry A. Jacobson, Kevin C. Maki, Carl E. Orringer, Peter H. Jones, Penny Kris-Etherton, Geeta Sikand, Ralph La Forge, Stephen R. Daniels, Don P. Wilson, Pamela B. Morris, Robert A. Wild, Scott M. Grundy, Martha Daviglus, Keith C. Ferdinand, Krishnaswami Vijayaraghavan, Prakash C. Deedwania, Judith A. Aberg, Katherine P. Liao, James M. McKenney, Joyce L. RossLynne T. Braun, Matthew K. Ito, Harold E. Bays, W. Virgil Brown

Research output: Contribution to journal › Article › peer-review

424 Scopus citations

Abstract

An Expert Panel convened by the National Lipid Association previously developed a consensus set of recommendations for the patient-centered management of dyslipidemia in clinical medicine (part 1). These were guided by the principle that reducing elevated levels of atherogenic cholesterol (non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol) reduces the risk for atherosclerotic cardiovascular disease. This document represents a continuation of the National Lipid Association recommendations developed by a diverse panel of experts who examined the evidence base and provided recommendations regarding the following topics: (1) lifestyle therapies; (2) groups with special considerations, including children and adolescents, women, older patients, certain ethnic and racial groups, patients infected with human immunodeficiency virus, patients with rheumatoid arthritis, and patients with residual risk despite statin and lifestyle therapies; and (3) strategies to improve patient outcomes by increasing adherence and using team-based collaborative care.

Original language	English (US)
Pages (from-to)	S1-S122.e1
Journal	Journal of Clinical Lipidology
Volume	9
Issue number	6
DOIs	https://doi.org/10.1016/j.jacl.2015.09.002
State	Published - Nov 1 2015

All Science Journal Classification (ASJC) codes

Internal Medicine
Endocrinology, Diabetes and Metabolism
Nutrition and Dietetics
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jacl.2015.09.002

Cite this

Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., Wild, R. A., Grundy, S. M., Daviglus, M., Ferdinand, K. C., Vijayaraghavan, K., Deedwania, P. C., Aberg, J. A., Liao, K. P., McKenney, J. M., ... Brown, W. V. (2015). National lipid association recommendations for patient-centered management of dyslipidemia: Part 2. Journal of Clinical Lipidology, 9(6), S1-S122.e1. https://doi.org/10.1016/j.jacl.2015.09.002

@article{4a44356bc83048ce98c58ef72c4d9fde,

title = "National lipid association recommendations for patient-centered management of dyslipidemia: Part 2",

abstract = "An Expert Panel convened by the National Lipid Association previously developed a consensus set of recommendations for the patient-centered management of dyslipidemia in clinical medicine (part 1). These were guided by the principle that reducing elevated levels of atherogenic cholesterol (non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol) reduces the risk for atherosclerotic cardiovascular disease. This document represents a continuation of the National Lipid Association recommendations developed by a diverse panel of experts who examined the evidence base and provided recommendations regarding the following topics: (1) lifestyle therapies; (2) groups with special considerations, including children and adolescents, women, older patients, certain ethnic and racial groups, patients infected with human immunodeficiency virus, patients with rheumatoid arthritis, and patients with residual risk despite statin and lifestyle therapies; and (3) strategies to improve patient outcomes by increasing adherence and using team-based collaborative care.",

author = "Jacobson, {Terry A.} and Maki, {Kevin C.} and Orringer, {Carl E.} and Jones, {Peter H.} and Penny Kris-Etherton and Geeta Sikand and {La Forge}, Ralph and Daniels, {Stephen R.} and Wilson, {Don P.} and Morris, {Pamela B.} and Wild, {Robert A.} and Grundy, {Scott M.} and Martha Daviglus and Ferdinand, {Keith C.} and Krishnaswami Vijayaraghavan and Deedwania, {Prakash C.} and Aberg, {Judith A.} and Liao, {Katherine P.} and McKenney, {James M.} and Ross, {Joyce L.} and Braun, {Lynne T.} and Ito, {Matthew K.} and Bays, {Harold E.} and Brown, {W. Virgil}",

note = "Publisher Copyright: {\textcopyright} 2015 National Lipid Association. Published by Elseiver Inc.",

year = "2015",

month = nov,

day = "1",

doi = "10.1016/j.jacl.2015.09.002",

language = "English (US)",

volume = "9",

pages = "S1--S122.e1",

journal = "Journal of Clinical Lipidology",

issn = "1933-2874",

publisher = "Elsevier BV",

number = "6",

}

Jacobson, TA, Maki, KC, Orringer, CE, Jones, PH, Kris-Etherton, P, Sikand, G, La Forge, R, Daniels, SR, Wilson, DP, Morris, PB, Wild, RA, Grundy, SM, Daviglus, M, Ferdinand, KC, Vijayaraghavan, K, Deedwania, PC, Aberg, JA, Liao, KP, McKenney, JM, Ross, JL, Braun, LT, Ito, MK, Bays, HE & Brown, WV 2015, 'National lipid association recommendations for patient-centered management of dyslipidemia: Part 2', Journal of Clinical Lipidology, vol. 9, no. 6, pp. S1-S122.e1. https://doi.org/10.1016/j.jacl.2015.09.002

TY - JOUR

T1 - National lipid association recommendations for patient-centered management of dyslipidemia

T2 - Part 2

AU - Jacobson, Terry A.

AU - Maki, Kevin C.

AU - Orringer, Carl E.

AU - Jones, Peter H.

AU - Kris-Etherton, Penny

AU - Sikand, Geeta

AU - La Forge, Ralph

AU - Daniels, Stephen R.

AU - Wilson, Don P.

AU - Morris, Pamela B.

AU - Wild, Robert A.

AU - Grundy, Scott M.

AU - Daviglus, Martha

AU - Ferdinand, Keith C.

AU - Vijayaraghavan, Krishnaswami

AU - Deedwania, Prakash C.

AU - Aberg, Judith A.

AU - Liao, Katherine P.

AU - McKenney, James M.

AU - Ross, Joyce L.

AU - Braun, Lynne T.

AU - Ito, Matthew K.

AU - Bays, Harold E.

AU - Brown, W. Virgil

PY - 2015/11/1

Y1 - 2015/11/1

N2 - An Expert Panel convened by the National Lipid Association previously developed a consensus set of recommendations for the patient-centered management of dyslipidemia in clinical medicine (part 1). These were guided by the principle that reducing elevated levels of atherogenic cholesterol (non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol) reduces the risk for atherosclerotic cardiovascular disease. This document represents a continuation of the National Lipid Association recommendations developed by a diverse panel of experts who examined the evidence base and provided recommendations regarding the following topics: (1) lifestyle therapies; (2) groups with special considerations, including children and adolescents, women, older patients, certain ethnic and racial groups, patients infected with human immunodeficiency virus, patients with rheumatoid arthritis, and patients with residual risk despite statin and lifestyle therapies; and (3) strategies to improve patient outcomes by increasing adherence and using team-based collaborative care.

AB - An Expert Panel convened by the National Lipid Association previously developed a consensus set of recommendations for the patient-centered management of dyslipidemia in clinical medicine (part 1). These were guided by the principle that reducing elevated levels of atherogenic cholesterol (non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol) reduces the risk for atherosclerotic cardiovascular disease. This document represents a continuation of the National Lipid Association recommendations developed by a diverse panel of experts who examined the evidence base and provided recommendations regarding the following topics: (1) lifestyle therapies; (2) groups with special considerations, including children and adolescents, women, older patients, certain ethnic and racial groups, patients infected with human immunodeficiency virus, patients with rheumatoid arthritis, and patients with residual risk despite statin and lifestyle therapies; and (3) strategies to improve patient outcomes by increasing adherence and using team-based collaborative care.

UR - http://www.scopus.com/inward/record.url?scp=84957953328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957953328&partnerID=8YFLogxK

U2 - 10.1016/j.jacl.2015.09.002

DO - 10.1016/j.jacl.2015.09.002

M3 - Article

C2 - 26699442

AN - SCOPUS:84957953328

SN - 1933-2874

VL - 9

SP - S1-S122.e1

JO - Journal of Clinical Lipidology

JF - Journal of Clinical Lipidology

IS - 6

ER -

National lipid association recommendations for patient-centered management of dyslipidemia: Part 2

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this